These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 45470)
1. Thyrotropin receptors in normal and pathological human thyroid tissues. Takahashi H; Jiang NS; Gorman CA; Lee CY J Clin Endocrinol Metab; 1978 Oct; 47(4):870-6. PubMed ID: 45470 [TBL] [Abstract][Full Text] [Related]
2. Presence of TSH receptor in thyroid neoplasms. Ichikawa Y; Saito E; Abe Y; Homma M; Muraki T J Clin Endocrinol Metab; 1976 Feb; 42(2):395-8. PubMed ID: 177443 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue. Clark OH; Gerend PL; Goretzki P; Nissenson RA J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132 [TBL] [Abstract][Full Text] [Related]
4. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)]. Abe Y Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386 [TBL] [Abstract][Full Text] [Related]
5. Receptors for thyroid-stimulating hormone in normal and pathological human thyroid tissues. Kermode JC; Edmonds CJ; Morgans ME J Endocrinol; 1984 Sep; 102(3):369-74. PubMed ID: 6090569 [TBL] [Abstract][Full Text] [Related]
6. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. Heyma P; Harrison LC J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581 [TBL] [Abstract][Full Text] [Related]
7. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells. Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672 [TBL] [Abstract][Full Text] [Related]
8. Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue. Ishii H; Inada M; Tanaka K; Mashio Y; Naito K; Nishikawa M; Imura H J Clin Endocrinol Metab; 1981 Jun; 52(6):1211-7. PubMed ID: 6894450 [TBL] [Abstract][Full Text] [Related]
9. TSH binding correlates with TSH-stimulated thyroid adenylate cyclase activity in human thyroid tissues. Duh QY; Siperstein AE; Miller RA; Smeds S; Clark OH Surgery; 1989 Dec; 106(6):967-73; discussion 973-4. PubMed ID: 2588124 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein. Mizukami Y; Hashimoto T; Nonomura A; Michigishi T; Nakamura S; Noguchi M; Matsukawa S J Clin Endocrinol Metab; 1994 Aug; 79(2):616-9. PubMed ID: 8045985 [TBL] [Abstract][Full Text] [Related]
11. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms. Saltiel AR; Powel-Jones CH; Thomas CG; Nayfeh SN Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptors in plasma membranes of normal and diseased human thyroid glands. Kanamori A; Abe Y; Yajima Y; Manabe Y; Ito K J Clin Endocrinol Metab; 1989 May; 68(5):899-903. PubMed ID: 2715291 [TBL] [Abstract][Full Text] [Related]
13. Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma. Abe Y; Ichikawa Y; Muraki T; Ito K; Homma M J Clin Endocrinol Metab; 1981 Jan; 52(1):23-8. PubMed ID: 6256403 [TBL] [Abstract][Full Text] [Related]
14. Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase. Lefort GP; Amr S; Carayon P; Nisula BC Endocrinology; 1984 Mar; 114(3):1005-11. PubMed ID: 6321134 [TBL] [Abstract][Full Text] [Related]
15. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease. Shinozawa T; Villadolid MC; Ingbar SH J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173 [TBL] [Abstract][Full Text] [Related]
16. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor. Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288 [TBL] [Abstract][Full Text] [Related]
17. Thyroid functional status and TSH receptors of cold nodular tissue. Djurica S; Misković D; Ratković M; Ribarac-Stepić N Endocrinol Exp; 1989 Dec; 23(4):279-86. PubMed ID: 2620659 [TBL] [Abstract][Full Text] [Related]
18. Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue. Brönnegård M; Törring O; Böös J; Sylven C; Marcus C; Wallin G J Clin Endocrinol Metab; 1994 Aug; 79(2):384-9. PubMed ID: 8045952 [TBL] [Abstract][Full Text] [Related]
19. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms. Clark OH; Gerend PL Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305 [TBL] [Abstract][Full Text] [Related]
20. Increased thyrotropin binding in hyperfunctioning thyroid nodules. Müller-Gärtner HW; Schneider C; Bay V; Tadt A; Rehpenning W; de Heer K; Jessel M Horm Metab Res; 1987 Aug; 19(8):382-5. PubMed ID: 3666673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]